(NASDAQ:CRBP), NORWOOD, Mass., May 22, 2025 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will provide a corporate update and participate in one-on-one investor meetings at the Jefferies Global Healthcare Conference, to be held June 3-5, 2025 in New […]
WESTLAKE, Texas, May 22, 2025 (GLOBE NEWSWIRE) — Stansberry Asset Management (“SAM”) has been named to the celebrated PSN Top Guns List of best performing separate accounts, managed accounts, and managed ETF strategies for Q1 2025. The highly anticipated list, published by Zephyr, remains one of the most important references for investors and asset managers.
CAMBRIDGE, Mass., May 22, 2025 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management will participate in the Jefferies Global Healthcare Conference on June 3, 2025. Format: 1×1 Meetings Date: Tuesday, June 3, 2025 Location: New York Marriott Marquis, New
BOSTON, May 22, 2025 (GLOBE NEWSWIRE) — Rhino Federated Computing, the leading platform for federated AI collaboration, today announced the close of an oversubscribed $15 million Series A funding round led by AlleyCorp. All existing institutional investors participated, including LionBird, Fusion Fund, Arkin Digital Health, Qiming Venture Partners USA, Telus Global Ventures and Keren Maccabi,
SAN FRANCISCO, CA & LONDON, UK, May 22, 2025 (GLOBE NEWSWIRE) — Watershed, the leading enterprise sustainability platform, today announced Open CEDA, a free version of its global emissions factor database the Comprehensive Environmental Data Archive (CEDA). The database, which covers 148 countries, 400 industries, and 95% of global GDP, aims to address critical gaps
(NASDAQ:AVO), OXNARD, Calif., May 22, 2025 (GLOBE NEWSWIRE) — Mission Produce, Inc. (NASDAQ: AVO) (“Mission” or “the Company”) a world leader in sourcing, producing, and distributing fresh Hass avocados, today announced it will release its financial results for the fiscal second quarter ended April 30, 2025 after the market closes on Thursday, June 5, 2025.
(TASE:SOFW),(TASE:SOFW.TA), SAN CLEMENTE, Calif., May 22, 2025 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced that Assaf Korner, Chief Financial Officer, will provide a corporate overview and participate in one-on-one investor meetings at the Jefferies Global Healthcare Conference, to
(Paris:IVA), Daix, May 22, 2025 Pursuant to Article 241-2 of the AMF General Regulations (Reglement General de l'Autorite des marches financiers), the purpose of this description is to present the objectives and terms of the Company's share repurchase program approved by the Ordinary General Meeting of May 22, 2025, it being specified that the Company
LONDON, May 22, 2025 (GLOBE NEWSWIRE) — Collaboration brings together R3's leading private enterprise blockchain with Solana's high performance public mainnet Drives institutional adoption of public blockchain networks, capitalizing on greater regulatory clarity and growing institutional demand for tokenized real-world assets (RWAs) Announcement marks new strategic direction for R3, signalling its leadership in driving the
Innovative Eclipsys(R) platform enables rational design of novel Targeted Glues(TM) with superior drug-like properties Cambridge, UK, 22 May 2025 – Amphista Therapeutics, a leader in the discovery of next-generation, Targeted Protein Degradation (TPD) medicines, has today presented the Company's unique approach to constructing novel, orally bioavailable Targeted Glue(TM) protein degraders with mechanisms of action (MoA)